New research presented today at the American Psychiatric Association’s Annual Meeting in San Francisco evaluated how accurately a self-reporting tool predicts difficult-to-treat depression, finding that the Difficult-to-Treat Depression Questionnaire (DTDQ) helps identify patients with a lower probability of depression remission before they experience treatment failures.
Continue Reading this article here
